AngioDynamics, Inc.

NASDAQ:ANGO

Medical - Instruments & Supplies

Healthcare
$11.32 +1.71%

+$0.20 today

Market cap
$476.06M
Beta
0.36
P/E (TTM)
-15.8
EPS (TTM)
-$0.75
52W Low $8.36High $13.99

Volume 0.32M

Average 0.40M

ANGO Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

AngioDynamics, Inc.NASDAQ: ANGO

Operating Margin · Q3 FY2026 · quarter ended Feb 2026

Operating margin widens to -8.2%

Operating margin was -8.2% in Q3 FY2026, up 5.7 pp from a year earlier. On a trailing-twelve-month basis it was -8.1%, up 9.1 pp year over year. Over 3 fiscal years it narrowed by 4.7 pp.

Context

  • Operating margin widened in 1 of the last 3 fiscal years.

What to watch

Whether operating margin reaches the consensus estimate from 3 analysts of -2.0% for the fiscal year ending May 2026, up from -13.7% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterFeb 2026
-8.2%-5.1 pp QoQ
Last fiscal yearMay 2025
-13.7%+49.7 pp YoY
LTMFeb 2026
-8.1%+9.1 pp YoY
Operating Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+5.7 pp+0.1 pp-5.5 pp
1 year+49.7 pp+11.6 pp-38.0 pp
3 years-4.7 pp+12.5 pp+17.2 pp
5 years+18.6 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Margin history

Percent of revenue · from the income statement

Latest · FY2025
-13.7%
Year-over-year change
+49.7pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Margin vs competitors

How ANGO compares with its peers on the latest reported figures

  • ANGO's LTM Feb 2026 operating margin of -8.1% is the lowest of the 9 companies compared; the peer median is 12.1%.
  • Its year-over-year change of +9.1 pp is the highest of 9, against a peer median of +0.8 pp.
  • Over three fiscal years its change of -4.7 pp compares with a peer median of +4.1 pp.
ANGO Competitors Peer median
Operating Margin for ANGO and competitors
Company Period LTM level YoY 3-year change
LMATLeMaitre Vascular, Inc.LTM Mar 202628.5% +5.1 pp+10.6 pp
BSXBoston Scientific CorporationLTM Jun 202621.5% +5.4 pp+5.4 pp
MMSIMerit Medical Systems, Inc.LTM Sep 202613.5% +1.5 pp+4.6 pp
PENPenumbra, Inc.LTM Jun 202612.4% +0.0 pp+12.8 pp
BDXBecton, Dickinson and CompanyLTM Sep 202611.8% -0.0 pp+0.7 pp
CNMDCONMED CorporationLTM Mar 202611.2% -2.3 pp+3.6 pp
IARTIntegra LifeSciences Holdings CorporationLTM Mar 20267.5% +7.0 pp-11.2 pp
TFXTeleflex IncorporatedLTM Jun 20263.3% -7.2 pp-5.1 pp
ANGOAngioDynamics, Inc.LTM Feb 2026-8.1% +9.1 pp-4.7 pp
Peer median (excluding ANGO) 12.1%+0.8 pp+4.1 pp

Competitors are the stored peer set for ANGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
May 2021
FY2022
May 2022
FY2023
May 2023
FY2024
May 2024
FY2025
May 2025
Revenue291.01M316.22M338.75M303.91M292.5M
Cost of Revenue134.22M150.49M164.51M149.22M134.79M
Gross Profit156.79M165.73M174.25M154.7M157.71M
Gross Margin53.9%52.4%51.4%50.9%53.9%
Research & Development36.39M30.74M29.88M31.51M26.22M
Selling, General & Admin117.22M133.75M144.25M143.98M145.23M
Operating Expenses192.07M194.2M225.43M347.13M197.66M
Depreciation & Amortization25.92M29.35M30.87M27.71M25.8M
EBITDA(9.28M)11.13M12.19M(6.13M)1.74M
EBITDA Margin-3.2%3.5%3.6%-2.0%0.6%
Operating Income(35.28M)(28.47M)(51.18M)(192.44M)(39.95M)
Operating Margin-12.1%-9.0%-15.1%-63.3%-13.7%
Interest Income0001.61M978K
Interest Expense861K688K2.7M00
Other Income / Expenses(769K)(1.48M)(3.26M)797K5.92M
Income Before Tax(36.05M)(29.95M)(54.44M)(191.64M)(34.03M)
Pre-Tax Margin-12.4%-9.5%-16.1%-63.1%-11.6%
Income Tax Expense(4.5M)(3.4M)(2M)(7.29M)(39K)
Net Income(31.55M)(26.55M)(52.44M)(184.35M)(33.99M)
Net Margin-10.8%-8.4%-15.5%-60.7%-11.6%
EPS (Basic)(0.82)(0.68)(1.33)(4.59)(0.83)
EPS (Diluted)(0.82)(0.68)(1.33)(4.59)(0.83)
Weighted Avg Shares38.34M39.01M39.48M40.18M40.98M
Weighted Avg Shares (Diluted)38.34M39.01M39.48M40.18M40.98M

AngioDynamics, Inc.

NASDAQ:ANGO

Intrinsic Alpha fair value

Locked

Current Price

$11.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.